Shanghai, China — Recently, MicroPort® CardioFlow Medtech Corporation (hereinafter referred to as MicroPort® CardioFlow, stock code: 02160.HK) has received marketing approval for its second-generation balloon catheter , Alwide® Plus Balloon Catheter (hereinafter referred to as "Alwide® Plus") from Russian State Food and Drug Administration(RZN).
As an upgraded product of Alwide® balloon catheter, Alwide® Plus was approved by the China National Drug Administration (NMPA) on July 29, 2021, and its excellent performance has been widely recognized by the surgeons after its launch: Its ultra-low compliance can realize more precise balloon expansion to avoid vascular damage; high burst pressure performance can effectively expand the site of severe calcification, which can better cope with the characteristics of Chinese patients with high calcification; fast filling and pumping performance can minimize the impact of prolonged blood flow blockage on cardiac function, reduce the pacing time, and lower the risk of surgery; significantly improved anti-puncture performance can further increase the safety of balloon dilatation while bringing the surgeons a better experience.
The approval of Alwide® Plus in Russia will help local TAVI physicians to cope with more challenges in different types of surgeries. At the same time, MicroPort® CardioFlow’s self-developed VitaFlow Liberty® Transcatheter Aortic Valve and Retrievable Delivery System has also made progress in its registration in Russia, steadily moving forward on the path of international development.
In the future, MicroPort® CardioFlow will develop more innovative products with international competitiveness, and provide high-quality, universal total solutions for structural heart disease to more patients around the world.
Notes:
[1] MicroPort® CardioFlow Laboratory Test Data (compared with Alwide® balloon catheter)
©Copyright 1998-2023, MicroPort CardioFlow Medtech Corporation. All rights reserved. | 网站备案/许可证号:沪ICP备2023023560号 沪公网安备 31011502014876号
互联网药品信息服务资格证书编号:(沪)-非经营性 - 2024 - 0135
“MicroPort CardioFlow”及“ are registered trademarks of MicroPort CardioFlow Medtech Corporation.